bexarotene
- Product NDC
- 0591-2832
- 11-digit product format
- 005912832
- Labeler code
- 0591
- Product ID
- 0591-2832_76dd1532-aa15-4e10-a26f-3cb25fbf8c1f
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- bexarotene
- Dosage form
- CAPSULE, LIQUID FILLED
- Route
- ORAL
- Labeler
- Actavis Pharma, Inc.
- Application
- ANDA209931
- Marketing category
- ANDA
- Marketing start
- 2021-11-11
- Substance
- BEXAROTENE
- Active strength
- 75 mg/1
- Pharmacologic classes
- Retinoid [EPC], Retinoids [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- bexarotene
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| BEXAROTENE | 75 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | A61RXM4375 |
| Rxcui | 308725 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 0591-2832-01 | bexarotene | 100 in 1 BOTTLE | CAPSULE, LIQUID FILLED | 100 | | 8 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 0591-2832 | BEXAROTENE CAPSULE, LIQUID FILLED [ACTAVIS PHARMA, INC.] | 8 | Current NDC, Legacy NDC, 1 package rows | 20250205_3292c63c-052f-4f28-b739-530a86e660bf.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0591-2832-01 | 00591283201 | 100 CAPSULE, LIQUID FILLED in 1 BOTTLE (0591-2832-01) | 2021-11-11 | 0000-00-00 | No | No | Current |